Cellular markers of eryptosis are altered in type 2 diabetes

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Free light chains in the cerebrospinal fluid. Do we still need oligoclonal IgG?
4. Reviews
5. Obese phenotype and natriuretic peptides in patients with heart failure with preserved ejection fraction
6. Prognostic value of HE4 in patients with ovarian cancer
7. Opinion Paper
8. Laboratory hemostasis: from biology to the bench
9. Genetics and Molecular Diagnostics
10. Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology
11. General Clinical Chemistry and Laboratory Medicine
12. IL8 and IL16 levels indicate serum and plasma quality
13. “Send & hold” clinical decision support rules improvement to reduce unnecessary testing of vitamins A, E, K, B1, B2, B3, B6 and C
14. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes
15. Search for new biomarkers of pediatric multiple sclerosis: application of immunoglobulin free light chain analysis
16. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings
17. Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents
18. LC-MSMS assays of urinary cortisol, a comparison between four in-house assays
19. Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis
20. Quantitative urine test strip reading for leukocyte esterase and hemoglobin peroxidase
21. Performance evaluation of cobas HBV real-time PCR assay on Roche cobas 4800 System in comparison with COBAS AmpliPrep/COBAS TaqMan HBV Test
22. Systematic comparison of routine laboratory measurements with in-hospital mortality: ICU-Labome, a large cohort study of critically ill patients
23. Reference Values and Biological Variations
24. Establishing reference intervals for sex hormones and SHBG in apparently healthy Chinese adult men based on a multicenter study
25. Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population
26. Cancer Diagnostics
27. Analytical validation of the Hevylite assays for M-protein quantification
28. Cardiovascular Diseases
29. Assessing matrix, interferences and comparability between the Abbott Diagnostics and the Beckman Coulter high-sensitivity cardiac troponin I assays
30. Infectious Diseases
31. Evaluation of a novel prognostic score based on thrombosis and inflammation in patients with sepsis: a retrospective cohort study
32. Letters to the Editor
33. Independent evaluation using fresh patient samples under real clinical conditions is vital for confirming the suitability and marketability of any new HbA_1c assay. An example
34. Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests
35. Site-specific DNA methylation detection based on enzyme-linked immunosorbent assay using recombinant methyl-CpG binding protein
36. 3q29 microduplication in a small family with complex metabolic phenotype from Southern Italy
37. A D1424N mutation in the MYH9 gene results in macrothrombocytopenia and granulocytic inclusion bodies in a Chinese inherited macrothrombocytopenia pedigree
38. Evaluation of analytical performance of a chemiluminescence enzyme immunoassay (CLEIA) for cTnI using the automated AIA-CL2400 platform
39. Cellular markers of eryptosis are altered in type 2 diabetes
40. Platelet serotonin is not elevated in patients with benign head and neck paragangliomas